User menu

Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives.

Bibliographic reference Buts, Jean-Paul. Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives.. In: Digestive diseases and sciences, Vol. 54, no. 1, p. 15-8 (2009)
Permanent URL
  1. Ducluzeau R, Bensaada M (1982) Comparative effect of a single or continuous administration of “Saccharomyces boulardii” on the establishment of various strains of “candida” in the digestive tract of gnotobiotic mice. Ann Microbiol (Paris) 133:491–501
  2. Surawicz Christina M., Elmer Gary W., Speelman Pieter, McFarland Lynne V., Chinn Janet, Van Belle Gerald, Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study, 10.1016/0016-5085(89)91613-2
  3. Szajewska H, Mrukowicz J (2005) Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 22:365–372
  4. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324:1361
  5. Szajewska H, Skorka A, Dylag M (2007) Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25:257–264
  6. Kurugol Z, Koturoglu G (2005) Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94:44–47
  7. Mansour-Ghanaei Fariborz, Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis, 10.3748/wjg.v9.i8.1832
  8. Besirbellioglu BA, Ulcay A, Can M, Erdem H, Tanyuksel M, Avci IY, Araz E, Pahsa A (2006) Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis 38:479–481
  9. Buts JP, Corthier G, Delmee M (1993) Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants. J Pediatr Gastroenterol Nutr 16:419–425
  10. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL, Noorani Z et al (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 272:518
  11. McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101:812–822
  12. Brar Harpreet S, Surawicz Christina M, Pseudomembranous Colitis: An Update, 10.1155/2000/324025
  13. McFarland LV (2007) Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis 5:97–105
  14. Kollaritsch H, Holst H, Grobara P, Wiedermann G (1993) Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr Med 111:152–156
  15. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A (2002) Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744–2749
  16. Duman DG, Bor S, Ozutemiz O, Sahin T, Oguz D, Istan F, Vural T, Sandkci M, Isksal F, Simsek I, Soyturk M, Arslan S, Sivri B, Soykan I, Temizkan A, Bessk F, Kaymakoglu S, Kalayc C (2005) Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol 17:1357–1361
  17. Gaon D, Garcia H, Winter L, Rodriguez N, Quintas R, Gonzalez SN, Oliver G (2003) Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 63:293–298
  18. Saint-Marc T, Rossello-Prats L, Touraine JL (1991) Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne (Paris) 142:64–65
  19. Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 45:1462–1464
  20. Guslandi M, Giollo P, Testoni PA (2003) A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 15:697–698
  21. Tempe JD, Steidel AL, Blehaut H, Hasselmann M, Lutun P, Maurier F (1983) Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding. Sem Hop 59:1409–1412
  22. Bleichner G, Blehaut H, Mentec H, Moyse D (1997) Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 23:517–523
  23. Herek O (2002) Saccharomyces boulardii: a possible addition to the standard treatment and prophylaxis of enterocolitis in Hirschsprung’s disease? Pediatr Surg Int 18:567
  24. Szajewska H, Ruszczynski M, Radzikowski A (2007) Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 150:113–114
  25. Johnston BC, Supina AL, Ospina M, Vohra S (2007) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 18:CD004827
  26. Villarruel G, Rubio DM, Lopez F, Cintioni J, Gurevech R, Romero G, Vandenplas Y (2007) Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Paediatr 96:538–541
  27. Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, Kontaxaki F, Petrochilou V (2003) Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 74:89–96
  28. Linday LA (2001) Saccharomyces boulardii: potential adjunctive treatment for children with autism and diarrhea. J Child Neurol 16:387
  29. Maupas JL, Champemont P, Delforge M (1983) Treatment of irritable bowel syndrome with Saccharomyces boulardii: a double blind, placebo controlled study. Med Chir Dig 12:77–79
  30. Buts JP, Bernasconi P (2005) Saccharomyces boulardii: basic science and clinical applications in gastroenterology. Gastroenterol Clin North Am 34:515–532
  31. Buts JP, De Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1297–1508
  32. Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics—Saccharomyces boulardii. Aliment Pharmacol Ther 26:767–778
  33. Edwards-Ingram L, Gitsham P, Burton N, Warhurst G, Clarke I, Hoyle D, Oliver SG, Stateva L (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73:2458–2467
  34. Malgoire JY, Bertout S, Renaud F, Bastide JM, Mallie M (2005) Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism. J Clin Microbiol 43:1133–1137
  35. Mitterdorfer G, Mayer HK, Kneifel W, Viernstein H (2002) Clustering of Saccharomyces boulardii strains within the species S. cerevisiae using molecular typing techniques. J Appl Microbiol 93:521–530
  36. van der Aa Kühle A, Jespersen L (2003) The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst Appl Microbiol 26:564–571
  37. Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 20:192–196
  38. Buts JP, Bernasconi P, Vaerman JP, Dive C (1990) Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci 35:251–256
  39. Buts JP, De Keyser N, Marandi S, Hermans D, Sokal EM, Chae YH, Lambotte L, Chanteux H, Tulkens PM (1999) Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats. Gut 45:89–96
  40. Buts JP, De Keyser N, Stilmant C, Sokal E, Marandi S (2002) Related articles, links Saccharomyces boulardii enhances N-terminal peptide hydrolysis in suckling rat small intestine by endoluminal release of a zinc-binding metalloprotease. Pediatr Res 51:528–534
  41. Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E (2006) Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr Res 60:24–29
  42. Buts Jean-Paul, Keyser Nadine De, Raedemaeker Laurence De, Saccharomyces boulardii Enhances Rat Intestinal Enzyme Expression by Endoluminal Release of Polyamines, 10.1203/00006450-199410000-00019
  43. Buts JP, De Keyser N, Kolanowski J, Sokal E, Van Hoof F (1993) Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines. Dig Dis Sci 38:1091–1098
  44. Wery I, Exogenous spermine induces maturation of the liver in suckling rats, 10.1053/jhep.1996.v24.pm0008903399
  45. Marandi S, De Keyser N, Saliez A, Maernoudt AS, Sokal EM, Stilmant C, Rider MH, Buts JP (2001) Insulin signal transduction in rat small intestine: role of MAP kinases in expression of mucosal hydrolases. Am J Physiol Gastrointest Liver Physiol 280:G229–240
  46. Marandi Soheila, De Keyser Nadine, Stilmant Catherine, Saliez Alain, Sokal Etienne Marc, Guiot Yves, Buts Jean-Paul, Ontogeny of MAP Kinases in Rat Small Intestine: Premature Stimulation by Insulin of BBM Hydrolases Is Regulated by ERKs but not by p-38 MAP Kinase, 10.1203/00006450-200208000-00009
  47. Kolch W (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6:827–837
  48. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285:1028–1032
  49. Dikic I, Blaukat A (1999) Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling. Cell Biochem Biophys 30:369–387